FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market
FDA has requested that the weight-loss drug Belviq, Belviq XR be withdrawn from the U.S. market because a safety clinical…
Is cross-border e-commerce air cargo demand at risk?
The looming demise of the de minimis exemption could spur higher costs and delays, said Xeneta’s Niall van de Wouw.
FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis
FDA requires a Boxed Warning about serious mental health side effects for the asthma & allergy drug Singulair (montelukast). Only…
FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems
FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due…
FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid
FDA warns that NSAID use at 20 weeks or later in pregnancy may cause serious kidney problems in an unborn…
Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib)
Preliminary safety trial results show an increased risk of serious heart-related problems and cancer with Xeljanz, Xeljanz XR (tofacitinib). FDA…
FDA warns that abuse and misuse of the nasal decongestant propylhexedrine causes serious harm
FDA warns that abuse and misuse of the over-the-counter nasal decongestant propylhexedrine causes serious heart and mental health problems, disability…
Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart disease
Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart…
Due to risk of serious liver injury, FDA restricts use of Ocaliva (obeticholic acid) in primary biliary cholangitis (PBC) patients with advanced cirrhosis
Due to risk of serious liver injury, FDA restricts use of Ocaliva (obeticholic acid) in primary biliary cholangitis (PBC) patients…
FDA warns that vapors from alcohol-based hand sanitizers can have side effects
FDA warns that headache, nausea, and dizziness can occur after applying alcohol-based hand sanitizers to the skin and breathing in…